New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:10 EDTEVGN, MBIIEvogene, Marrone Bio sign multi-year collaborative agreement
Evogene (EVGN) and Marrone Bio Innovations (MBII) announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies. The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field. The companies will utilize the collaboration's joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while MBI will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration
News For EVGN;MBII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
16:03 EDTMBIIMarrone Bio receives NASDAQ notice regarding late 10-K filing
Marrone Bio Innovations announced that, as anticipated, it has received a letter from the Listing Qualifications Department of NASDAQ notifying MBI of its noncompliance with NASDAQ listing rules as a result of the company’s Notification of Late Filing on Form 12b-25 on April 1. The company previously indicated that the filing of its annual report on Form 10-K for the year ended December 31, 2014 will be delayed until after the completion of company management’s evaluation of the necessity, nature and scope of any restatements to its previously filed financial statements. The NASDAQ letter states that the company is required to submit, no later than April 17, an update to its plan to file any delinquent reports by May 13 and to regain compliance with NASDAQ’s filing requirements for continued listing.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use